Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model

被引：0
|
作者：
Margarite D. Matossian
Hope E. Burks
Steven Elliott
Van T. Hoang
Annie C. Bowles
Rachel A. Sabol
Bahia Wahba
Muralidharan Anbalagan
Brian Rowan
Mohamed E. Abazeed
Bruce A. Bunnell
Krzysztof Moroz
Lucio Miele
Lyndsay V. Rhodes
Steven D. Jones
Elizabeth C. Martin
Bridgette M. Collins-Burow
Matthew E. Burow
机构：
[1] Tulane University School of Medicine,Department of Medicine, Section of Hematology & Medical Oncology
[2] Tulane University School of Medicine,Department of Pharmacology
[3] Tulane Center for Stem Cell Research and Regenerative Medicine,Department of Structural and Cellular Biology
[4] Tulane University,Department of Pathology
[5] Cleveland Clinic,Department of Surgery
[6] Department of Radiation Oncology,Department of Genetics and Stanley S. Scott Cancer Center
[7] Tulane Cancer Center,Department of Biology
[8] Tulane University School of Medicine,Department of Agricultural Engineering
[9] Tulane University School of Medicine,undefined
[10] Louisiana Cancer Research Center,undefined
[11] Biospecimen Core,undefined
[12] Louisiana State University Health Sciences Center,undefined
[13] Florida Gulf Coast University,undefined
[14] Louisiana State University,undefined
来源：
BMC Cancer | / 19卷
关键词：
Triple-negative breast cancer; Patient-derived xenograft; Mammosphere; Chemoresistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] A clinically relevant prognostic mRNA signature for triple-negative breast cancer developed from the patient-derived xenograft model
    Moon, Hyeong-Gon
    Oh, Keunhee
    Lee, Dong-Sup
    Han, Wonshik
    Noh, Dong-Young
    [J]. MOLECULAR CANCER RESEARCH, 2013, 11
  • [22] Circulating tumor cell monitoring, isolation, and culture from a patient with metastatic triple-negative breast cancer for drug screening and creation of a patient-derived xenograft model
    Ramirez, Arturo B.
    Blau, C. Anthony
    Martins, Timothy J.
    Mahen, Elisabeth
    Dobrolecki, Lacey E.
    Lewis, Michael T.
    Stilwell, Jackie L.
    Kaldjian, Eric P.
    [J]. CANCER RESEARCH, 2017, 77
  • [23] EXAMINING THE ROLE OF LEPTIN SIGNALING IN A PATIENT-DERIVED MODEL OF TRIPLE NEGATIVE BREAST CANCER
    Brock, C.
    Wright, M.
    Nguyen, K.
    Cheng, T.
    Collins-Burow, B.
    Bunnell, B.
    Burow, M.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (02) : 672 - 672
  • [24] Rewiring of the 3D genome during acquisition of carboplatin resistance in a triple-negative breast cancer patient-derived xenograft
    Mikhail G. Dozmorov
    Maggie A. Marshall
    Narmeen S. Rashid
    Jacqueline M. Grible
    Aaron Valentine
    Amy L. Olex
    Kavita Murthy
    Abhijit Chakraborty
    Joaquin Reyna
    Daniela Salgado Figueroa
    Laura Hinojosa-Gonzalez
    Erika Da-Inn Lee
    Brittany A. Baur
    Sushmita Roy
    Ferhat Ay
    J. Chuck Harrell
    [J]. Scientific Reports, 13 (1)
  • [25] Treatment naive patient-derived xenograft model compared to the post-neoadjuvant model from the same patient diagnosed with triple negative breast cancer
    Windsor, Gabrielle Olivia
    Matossian, Margarite
    Wright, Maryl
    Elliott, Steven
    Nguyen, Khoa
    Collins-Burow, Bridgette
    Burow, Matthew
    [J]. CANCER RESEARCH, 2021, 81 (04)
  • [26] Overcoming PARP inhibitor resistance with molecularly guided rational combinations in triple-negative breast cancer patient-derived xenograft models
    Pico, Christian X. Cruz
    Evans, Kurt W.
    Chen, Ken
    Zheng, Xiaofeng
    Akcakanat, Argun
    Zhao, Ming
    Tapia, Coya
    Scott, Stephen M.
    Yuca, Erkan
    Meric-Bernstam, Funda
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [27] A Single Low Dose of Eribulin Regressed a Highly Aggressive Triple-negative Breast Cancer in a Patient-derived Orthotopic Xenograft Model
    Lim, Hye In
    Yamamoto, Jun
    Inubushi, Sachiko
    Nishino, Hiroto
    Tashiro, Yoshihiko
    Sugisawa, Norihiko
    Han, Quinhong
    Sun, Yu
    Choi, Hee Jun
    Nam, Seok Jin
    Kim, Moon Bo
    Lee, Ji Sun
    Hozumi, Chihiro
    Bouvet, Michael
    Singh, Shree Ram
    Hoffman, Robert M.
    [J]. ANTICANCER RESEARCH, 2020, 40 (05) : 2481 - 2485
  • [28] Response of Triple-negative Breast Cancer Liver Metastasis to Oral Recombinant Methioninase in a Patient-derived Orthotopic Xenograft (PDOX) Model
    Lim, Hye In
    Yamamoto, Jun
    Han, Qinhong
    Sun, Y. U.
    Nishino, Hiroto
    Tashiro, Yoshihiko
    Sugisawa, Norihiko
    Tan, Yuying
    Choi, Hee Jun
    Nam, Seok Jin
    Bouvet, Michael
    Hoffman, Robert M.
    [J]. IN VIVO, 2020, 34 (06): : 3163 - 3169
  • [29] Carboplatin resistance-associated changes in the 3D chromatin landscape of a triple-negative breast cancer Patient-Derived Xenograft
    Dozmorov, Mikhail
    Marshall, Maggie
    Rashid, Narmeen
    Grible, Jacqueline
    Valentine, Aaron D.
    Olex, Amy
    Murthy, Kavita
    Chakraborty, Abhijit
    Reyna, Joaquin
    Figueroa, Daniela Salgado
    Lee, Da-Inn
    Baur, Brittany
    Roy, Sushmita
    Ay, Ferhat
    Harrell, Chuck
    [J]. CANCER RESEARCH, 2023, 83 (05)
  • [30] Evaluating the metastatic potential and the molecular heterogeneity of patient-derived orthotopic xenograft models of triple-negative breast cancer
    Ramani, Vishnu C.
    Gupta, Rakhi
    Quon, Gerald
    Triboulet, Melanie
    Renier, Corinne
    Greene, Cassandra
    Sanada, Chad
    Lu, Tracy
    Szpankowski, Lukasz
    Ramalingam, Naveen
    Salahudeen, Ameen A.
    de la O, Sean
    Rajapaksa, Ranjani
    Levy, Shoshana
    Leyrat, Anne A.
    West, Jay A.
    Sollier-Christen, Elodie
    Kuo, Calvin J.
    Sledge, George W.
    Jeffrey, Stefanie S.
    [J]. CANCER RESEARCH, 2017, 77
12345